Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya

被引:39
作者
Njomo, Doris W. [1 ]
Mukoko, Dunstan A. [2 ]
Nyamongo, Nipher K. [1 ]
Karanja, Joan [3 ]
机构
[1] Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya
[2] Minist Hlth, Div Vector Borne & Neglected Trop Dis, Nairobi, Kenya
[3] Minist Hlth, Malindi Dist Hosp, Malindi, Kenya
来源
PLOS ONE | 2014年 / 9卷 / 01期
基金
比尔及梅琳达.盖茨基金会;
关键词
DIETHYLCARBAMAZINE; PROGRAM; ALBENDAZOLE; IVERMECTIN; INFECTION; INDIA;
D O I
10.1371/journal.pone.0083413
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Implementation of Mass Drug Administration (MDA) in urban settings is an obstacle to Lymphatic Filariasis (LF) elimination. No urban-specific guidelines on MDA in urban areas exist. Malindi district urban area had received 4 MDA rounds by the time the current study was implemented. Programme data showed average treatment coverage of 28.4% (2011 MDA), far below recommended minimum of 65-80%. Methods: To identify, design and test strategies for increased treatment coverage in urban areas, a quasi-experimental study was conducted in Malindi urban area. Three sub-locations with lowest treatment coverage in 2011 MDA were purposively selected. In the pre-test phase, 947 household heads sampled using systematic random method were interviewed for quantitative data. For qualitative data, 12 Focus Group Discussions (FGDs) with single sex adult and youth male and female groups and 3 with community drug distributors (CDDs) were conducted. Forty in-depth interviews with opinion leaders and self-administered questionnaires with District Public Health officers purposively selected were carried out. The quantitative data were analyzed using SPSS version 16 and statistical significance assessed by x(2) test. The qualitative data were analyzed manually according to study's themes. Results and Discussion: The identified strategies were implemented prior to and during 2012 MDA in two sub-locations (experimental) while in the third (control), usual MDA strategies were applied. In the post-test phase, 2012 MDA coverage in experimental and control sub-locations was comparatively assessed for effect of the newly designed strategies on urban MDA. Results indicated improved treatment coverage in experimental sub-locations, 77.1% in Shella and 66.0% in Barani. Central (control) sub-location also attained high coverage, 70.4% indicating average treatment coverage of 71%. Conclusion: The identified strategies contributed to increased treatment coverage in experimental sites and should be applied in urban areas. Due to closeness of sites, spillover effects may have contributed to increased coverage in the control site.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
    Kura, Klodeta
    Stolk, Wilma A.
    Basanez, Maria-Gloria
    Collyer, Benjamin S.
    de Vlas, Sake J.
    Diggle, Peter J.
    Gass, Katherine
    Graham, Matthew
    Hollingsworth, T. Deirdre
    King, Jonathan D.
    Krentel, Alison
    Anderson, Roy M.
    Coffeng, Luc E.
    CLINICAL INFECTIOUS DISEASES, 2024, 78 : S93 - S100
  • [22] Factors influencing implementation of mass drug administration for lymphatic filariasis elimination: a mixed-method study in Odisha, India
    Ratna, P.
    Sinha, Abhinav
    Pati, Sanghamitra
    Sahoo, Prakash Kumar
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [23] Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India
    Babu, B
    Kar, SK
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (06) : 702 - 709
  • [24] COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA
    Kisoka, William J.
    Tersbol, Britt Pinkowsky
    Meyrowitsch, Dan W.
    Simonsen, Paul E.
    Mushi, Declare L.
    JOURNAL OF BIOSOCIAL SCIENCE, 2016, 48 (01) : 94 - 112
  • [25] Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted?
    Rebollo, Maria P.
    Mohammed, Khalfan A.
    Thomas, Brent
    Ame, Shaali
    Ali, Said Mohammed
    Cano, Jorge
    Gonzalez Escalada, Alba
    Bockarie, Moses J.
    PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (03):
  • [26] Factors Influencing Drug Uptake during Mass Drug Administration for Control of Lymphatic Filariasis in Rural and Urban Tanzania
    Kisoka, William J.
    Simonsen, Paul E.
    Malecela, Mwelecele N.
    Tersbol, Britt P.
    Mushi, Declare L.
    Meyrowitsch, Dan W.
    PLOS ONE, 2014, 9 (10):
  • [27] Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil
    Lima, Ana Wladia
    Medeiros, Zulma
    dos Santos, Zailde Carvalho
    da Costa, Gertrudes Monteiro
    Braga, Cynthia
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2012, 45 (06) : 745 - 750
  • [28] ADVERSE REACTIONS FOLLOWING MASS DRUG ADMINISTRATION WITH DIETHYLCARBAMAZINE AND ALBENDAZOLE FOR LYMPHATIC FILARIASIS ELIMINATION IN WEST SUMATERA, INDONESIA
    Widiastuti, Dyah
    Kesuma, Agung Puja
    Jastal
    Kusrini, Ina
    Wijayanti, Siwi Pramatama Mars
    Dhewantara, Pandji Wibawa
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2021, 52 (01) : 1 - 10
  • [29] Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration
    Simonsen, Paul E.
    Derua, Yahya A.
    Magesa, Stephen M.
    Pedersen, Erling M.
    Stensgaard, Anna-Sofie
    Malecela, Mwelecele N.
    Kisinza, William N.
    PARASITES & VECTORS, 2014, 7
  • [30] Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana
    Biritwum, Nana-Kwadwo
    Garshong, Bertha
    Alomatu, Bright
    de Souza, Dziedzom K.
    Gyapong, Margaret
    Kyelem, Dominique
    PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (05):